Sexually Transmitted Infections Treatment Guidelines, 2021
On July 10, 2025, King Pharmaceuticals, a subsidiary of Pfizer, of specific referenced lots of Bicillin® L-A (Penicillin G Benzathine Injectable Suspension). Further details and priority actions for health departments and healthcare providers are available from the Dear Colleague Letter.
On 1/16/2024, the FDA announced that they have (benzathine benzylpenicillin injection, powder, for suspension). See more in this . See more in this . , (Benzathine Benzylpenicillin Tetrahydrate) Powder and diluent for suspension for injection, has also been allowed since July of 2024.
Bicillin L-A® is the first-line recommended treatment for syphilis and the only recommended treatment option for some patients.
CDC continues to monitor the situation and will post updates as needed.
CDC’s Sexually Transmitted Infections (STI) Treatment Guidelines, 2021 provides current evidence-based prevention, diagnostic and treatment recommendations that replace the 2015 guidance. The recommendations are intended to be a source for clinical guidance. Healthcare providers should always assess patients based on their clinical circumstances and local burden.